Abstract
The development of new scales to characterize and quantify the noncognitive features of dementing illness has greatly facilitated advances in our understanding and ability to treat Alzheimer’s disease, vascular dementia, Lewy body dementia, and Parkinson’s dementia. This review recalls the history of the development of four of these scales, and summarizes some of the recent published literature on the noncognitive aspects of dementia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Current Psychosis & Therapeutics Reports
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
